Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类] 肿瘤学
[关键词] clinical trial;melanoma;IL-12;vaccination;Melan-A peptide;immunological monitoring [时效性]
